The mechanisms by which such dynamic changes in GR sensitivity associate with changes in PTSD symptoms remains to be fully elucidated; however the current findings suggest that the molecular mechanisms that regulate glucocorticoid signaling associate with treatment outcome. This evidence concerns the gene NR3C1 and post-traumatic stress disorder.